DETERMINATION OF CLINICAL COURSE AND OPTIMAL TREATMENT STRATEGIES IN THE OVERALL POPULATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Scientific Publications

• 1997 NEW ENGLAND JOURNAL OF MEDICINE

  Medical progress - The management of hypertrophic cardiomyopathy

• 1998 CIRCULATION RESEARCH

  A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity

• 2002 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

  Risk associated with pregnancy in hypertrophic cardiomyopathy

• 2005 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

  The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

• 1998 AMERICAN JOURNAL OF CARDIOLOGY

  Implications of left ventricular remodeling in hypertrophic cardiomyopathy

• 2000 NEW ENGLAND JOURNAL OF MEDICINE

  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

• 1997 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

  Clinical features of hypertrophic cardiomyopathy caused by mutation of a ''hot spot'' in the alpha-tropomyosin gene

• 1999 CIRCULATION

  Infective endocarditis in hypertrophic cardiomyopathy - Prevalence, incidence, and indications for antibiotic prophylaxis

• 2002 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

• 1999 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

  Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy